California AI Law vs Federal AI Law (2026): Full Comparison
There is no federal equivalent to AB 489, AB 3030, AB 2013, or SB 942. As of January 1, 2026, California operates an independent healthcare AI regulatory framework that imposes requirements that federal law does not address. Federal compliance is not California compliance. If your AI product reaches California patients or providers, you must satisfy California law regardless of your federal compliance status.
The central fact
California's 2026 AI laws are not preempted by federal law. HIPAA compliance, FDA clearance, FTC guideline adherence, and compliance with the White House Executive Order on AI do not satisfy — and in many cases do not address — the specific requirements of AB 489, AB 3030, AB 2013, or SB 942. You must comply with both.
Quick Reference: California Laws vs Their Closest Federal Analogues
| California Law | What It Requires | Closest Federal Analog | Federal Analog Sufficient? |
|---|---|---|---|
| AB 489 | AI must disclose it is not a licensed healthcare professional at the start of every patient interaction | FTC Act §5 (deceptive practices); FTC AI guidance | No — FTC prohibits deception; AB 489 requires affirmative disclosure |
| AB 3030 | GenAI clinical communications require human review OR specific disclaimer | HIPAA; HHS AI in Healthcare Guidance | No — HIPAA does not require AI disclosure or human review |
| AB 2013 | Public training data disclosure on company domain | No direct equivalent; some EO 14110 provisions | No — no federal law requires a public training data disclosure page |
| SB 942 | AI content watermarking; free detection tool for 1M+ CA user platforms | No direct equivalent; NIST AI RMF recommendations | No — NIST AI RMF is voluntary; SB 942 is mandatory law |
| SB 1120 | Licensed clinician must make final health insurance claim denial decisions | CMS utilization management rules; ERISA | No — federal rules allow AI to assist; SB 1120 requires human final decision |
AB 489 vs Federal AI Disclosure Standards
The FTC Act prohibits deceptive trade practices, which includes AI systems that falsely claim to be human. FTC guidance (2023) states AI in consumer contexts must not deceive users about its nature. But the FTC standard is reactive — it prohibits active deception.
AB 489 is proactive. It requires an affirmative, prominent disclosure at the start of every patient interaction that the system is not a licensed healthcare professional — even if the patient never asks and would not otherwise be deceived. The disclosure must appear before any clinical content is exchanged.
An AI virtual assistant that is clearly labeled "AI" in the app store but does not display a prominent clinical identity disclaimer at the start of each healthcare conversation may satisfy FTC non-deception standards while violating AB 489.
AB 3030 vs Federal Healthcare AI Requirements
The federal healthcare AI landscape in 2026 consists of: HIPAA (data privacy and security), FDA's Software as a Medical Device (SaMD) framework (device safety and efficacy), the HHS National AI Strategy (guidance, not binding law), and the CMS Innovation Center AI pilots (voluntary programs). None of these impose requirements equivalent to AB 3030.
The FDA's SaMD framework regulates whether a medical device is safe and effective — it does not require disclosure to patients when AI generates their clinical communications. HIPAA ensures patient data is protected — it does not require human review of AI outputs before they reach patients.
AB 3030 fills this gap by requiring human oversight or explicit disclosure at the specific point where AI output reaches the patient. It is the only law — state or federal — that currently creates this obligation for healthcare AI in the United States.
AB 2013 vs Federal Training Data Requirements
No federal law requires AI companies to publicly disclose their training data sources. The White House Executive Order 14110 (October 2023) required federal agencies to report on AI use and directed the development of AI safety standards, but did not impose public training data disclosure obligations on private companies.
The NIST AI Risk Management Framework (AI RMF) recommends transparency about AI training data as a governance best practice — but it is voluntary. The EU's AI Act (effective August 2024 for high-risk categories) requires some transparency about training data for high-risk AI systems, but that is EU law, not US federal law.
AB 2013, effective January 1, 2026, is the first mandatory training data public disclosure law in the United States for private-sector AI developers serving California users.
SB 942 vs Federal AI Watermarking
EO 14110 directed NIST to develop standards for detecting AI-generated content, but no federal watermarking mandate has been enacted. SB 942 imposes concrete obligations: AI content must carry manifest (visible) and latent (embedded) provenance markers, and platforms with 1 million or more monthly California users must provide a free, publicly accessible AI detection tool.
The C2PA standard (Coalition for Content Provenance and Authenticity, supported by Adobe, Microsoft, and others) is an industry standard that aligns with SB 942's latent watermarking requirements — but industry standard adoption is voluntary. SB 942 compliance is not.
SB 1120 vs Federal Utilization Management Rules
CMS has issued guidance on AI in utilization management (UM) for Medicare Advantage plans, emphasizing that AI cannot be the sole basis for coverage determinations. But CMS guidance is not statutory law; it is regulatory guidance without the same enforcement mechanism as SB 1120.
SB 1120 is California statute: a licensed, qualified clinician must make the final determination on health insurance claim denials. No AI tool can be the final decision-maker. For health plans operating in California, this is an enforceable legal obligation administered by the DMHC — not guidance.
The Preemption Question
Federal preemption of California AI law would require either: (1) an express federal preemption clause in a federal AI statute, or (2) a direct conflict between federal and California law where compliance with both is impossible.
As of 2026, no federal AI statute with an express preemption clause exists. California's AI laws do not conflict with federal law — they impose additional requirements on top of federal minimums. Courts have consistently held that state laws that impose higher standards than federal minimums are not preempted.
HIPAA does contain a preemption provision — but it expressly preserves state laws that provide greater patient privacy protections. California's CMIA (Confidentiality of Medical Information Act) has long survived on this basis. The California AI disclosure laws are broadly structured on the same principle.
What This Means for Healthcare AI Companies
Healthcare AI companies serving California patients must maintain parallel compliance frameworks:
- Federal: HIPAA (data privacy), FDA SaMD (device safety), FTC (consumer protection), CMS (if serving Medicare/Medicaid patients)
- California: AB 489, AB 3030, AB 2013, SB 942, SB 1120, CMIA, CCPA/CPRA
The good news: California compliance generally makes you more compliant with the spirit of federal guidance, even when not legally required. Companies that build AB 3030-compliant human oversight workflows are better positioned for anticipated federal UM oversight guidance. Companies that publish AB 2013 training data disclosures are proactively aligning with the direction of federal AI transparency policy.
Free compliance tools — covers California requirements federal law doesn't address